An expert panel of India's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E's Covid-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said.

The government has still not taken a decision on vaccinating those aged below 15 years. NITI Aayog member (Health) VK Paul at a press conference recently said that the additional need for vaccination and inclusion of population for vaccination is examined constantly. The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-unit vaccine against Covid-19, for restricted use in an emergency situation in adults on December 28. It has not been included in the country's vaccination drive.